Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).

Labriola, M; Zhu, J; Cheris, S; Liu, X; Perkinson, K; Su, ZW; McCall, S; Huang, JT; Gupta, RT; Armstrong, AJ; George, DJ; Zhang, T

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):